2. Search Result
Search Result
Results for "

bacterial bronchitis

" in MedChemExpress (MCE) Product Catalog:

27

Inhibitors & Agonists

1

Natural
Products

10

Isotope-Labeled Compounds

Targets Recommended:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-66011
    Moxifloxacin Hydrochloride
    Maximum Cited Publications
    15 Publications Verification

    BAY 12-8039

    		 Bacterial Antibiotic Infection Cancer
    Moxifloxacin Hydrochloride (BAY 12-8039) is an oral 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia .
    Moxifloxacin Hydrochloride
  • HY-B0198A
    Cefaclor monohydrate
    1 Publications Verification

    		 Antibiotic Bacterial Penicillin-binding protein (PBP) 5-HT Receptor Infection Neurological Disease Inflammation/Immunology
    Cefaclor is a well-absorbed orally active cephalosporin antibiotic. Cefaclor can specifically bind to specific for penicillin-binding protein 3 (PBP3). Cefaclor can be used for the research of depression and kinds of infections caused by bacteria, such as respiratory tract infections, bacterial bronchitis, pharyngitis and skin infections .
    Cefaclor monohydrate
  • HY-B0198
    Cefaclor
    1 Publications Verification

    		 Antibiotic Penicillin-binding protein (PBP) Bacterial 5-HT Receptor Infection Neurological Disease Inflammation/Immunology
    Cefaclor is a well-absorbed orally active cephalosporin antibiotic. Cefaclor can specifically bind to specific for penicillin-binding protein 3 (PBP3). Cefaclor can be used for the research of depression and kinds of infections caused by bacteria, such as respiratory tract infections, bacterial bronchitis, pharyngitis and skin infections .
    Cefaclor
  • HY-66011A
    Moxifloxacin
    Maximum Cited Publications
    15 Publications Verification

    BAY 12-8039 free base

    		 Bacterial Antibiotic Infection Cancer
    Moxifloxacin is an orally active 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia .
    Moxifloxacin
  • HY-135398
    Decarboxy Moxifloxacin

    		Bacterial Infection Inflammation/Immunology
    Decarboxy Moxifloxacin (compound 8) is a decarboxylated compound of Moxifloxacin. Moxifloxacin is an orally active 8-methoxyquinolone antimicrobial for use in acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia .
    Decarboxy Moxifloxacin
  • HY-66011AR
    Moxifloxacin (Standard)

    BAY 12-8039 free base (Standard)

    		 Reference Standards Bacterial Antibiotic Infection Cancer
    Moxifloxacin (Standard) is the analytical standard of Moxifloxacin. This product is intended for research and analytical applications. Moxifloxacin is an orally active 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia .
    Moxifloxacin (Standard)
  • HY-B0198R
    Cefaclor (Standard)

    		Antibiotic Reference Standards Penicillin-binding protein (PBP) Bacterial 5-HT Receptor Infection Neurological Disease Inflammation/Immunology
    Cefaclor (Standard) is the analytical standard of Cefaclor. This product is intended for research and analytical applications. Cefaclor is a well-absorbed orally active cephalosporin antibiotic. Cefaclor can specifically bind to specific for penicillin-binding protein 3 (PBP3). Cefaclor can be used for the research kinds of infections caused by bacteria, such as respiratory tract infections, bacterial bronchitis, pharyngitis and skin infections .
    Cefaclor (Standard)
  • HY-B0198AR
    Cefaclor monohydrate (Standard)

    		Antibiotic Reference Standards Bacterial Penicillin-binding protein (PBP) 5-HT Receptor Infection Neurological Disease Inflammation/Immunology
    Cefaclor (monohydrate) (Standard) is the analytical standard of Cefaclor (monohydrate). This product is intended for research and analytical applications. Cefaclor is a well-absorbed orally active cephalosporin antibiotic. Cefaclor can specifically bind to specific for penicillin-binding protein 3 (PBP3). Cefaclor can be used for the research of depression and kinds of infections caused by bacteria, such as respiratory tract infections, bacterial bronchitis, pharyngitis and skin infections .
    Cefaclor monohydrate (Standard)
  • HY-66011AS
    Moxifloxacin-d4

    BAY 12-8039-d4 free base

    		 Isotope-Labeled Compounds Bacterial Antibiotic Infection
    Moxifloxacin-d4 is the deuterium labeled Moxifloxacin. Moxifloxacin is an orally active 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia .
    Moxifloxacin-d4
  • HY-66011AS2
    Moxifloxacin-d3 hydrochloride

    BAY 12-8039-d3

    		 Bacterial Antibiotic Infection Cancer
    Moxifloxacin-d3 (hydrochloride) is the deuterium labeled Moxifloxacin hydrochloride. Moxifloxacin hydrochloride is an orally active 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia .
    Moxifloxacin-d3 hydrochloride
  • HY-66011S
    rac cis-Moxifloxacin-d4 hydrochloride

    rac cis-BAY 12-8039-d4

    		 Isotope-Labeled Compounds Bacterial Antibiotic Infection
    rac cis-Moxifloxacin-d4 (hydrochloride) is the deuterium labeled Moxifloxacin hydrochloride. Moxifloxacin Hydrochloride (BAY 12-8039) is an oral 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia .
    rac cis-Moxifloxacin-d4 hydrochloride
  • HY-66011R
    Moxifloxacin Hydrochloride (Standard)

    BAY 12-8039 (Standard)

    		 Reference Standards Bacterial Antibiotic Infection Cancer
    Moxifloxacin (Hydrochloride) (Standard) is the analytical standard of Moxifloxacin (Hydrochloride). This product is intended for research and analytical applications. Moxifloxacin Hydrochloride (BAY 12-8039) is an oral 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia .
    Moxifloxacin Hydrochloride (Standard)
  • HY-66011B
    (Rac)-Moxifloxacin

    (Rac)-BAY 12-8039 free base

    		 Bacterial Antibiotic Infection
    (Rac)-Moxifloxacin ((Rac)-BAY 12-8039 free base) is the isoform of Moxifloxacin Hydrochloride (HY-66011), which is an oral 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia .
    (Rac)-Moxifloxacin
  • HY-66011AS6
    Moxifloxacin-d4 hydrochloride

    BAY 12-8039-d4

    		 Isotope-Labeled Compounds Others
    Moxifloxacin-d4 hydrochloride (BAY 12-8039-d4) is the hydrochloride salt form of deuterium labeled Moxifloxacin (Moxifloxacin). Moxifloxacin is an orally active antimicrobial, that can be used in the research of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia .
    Moxifloxacin-d4 hydrochloride
  • HY-66011AS5
    Moxifloxacin-d5

    BAY 12-8039-d5 free base

    		 Isotope-Labeled Compounds Antibiotic Bacterial Infection Cancer
    Moxifloxacin-d5 (BAY 12-8039-d5 (free base)) is deuterium labeled Moxifloxacin. Moxifloxacin is an orally active 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia .
    Moxifloxacin-d5
  • HY-66011AS3
    Moxifloxacin-d3-1 hydrochloride

    BAY 12-8039-d3-1

    		 Isotope-Labeled Compounds Bacterial Antibiotic Infection
    Moxifloxacin-d3-1 hydrochloride (BAY 12-8039-d3-1) is a deuterium labeled Moxifloxacin (HY-66011A). Moxifloxacin is an orally active 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia .
    Moxifloxacin-d3-1 hydrochloride
  • HY-66011AS4
    Moxifloxacin-13C,d3 hydrochloride

    BAY 12-8039-13C,d3

    		 Isotope-Labeled Compounds Cancer
    Moxifloxacin- 13C,d3 hydrochloride (BAY 12-8039- 13C,d3) is 13C and deuterated labeled Moxifloxacin (HY-66011A). Moxifloxacin is an orally active 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia.
    Moxifloxacin-13C,d3 hydrochloride
  • HY-66011BS
    (Rac)-Moxifloxacin-d4

    (Rac)-BAY 12-8039-d4 free base

    		 Isotope-Labeled Compounds Antibiotic Bacterial Infection
    (Rac)-Moxifloxacin-d4 ((Rac)-BAY 12-8039-d4 (free base)) is deuterium labeled (Rac)-Moxifloxacin. (Rac)-Moxifloxacin ((Rac)-BAY 12-8039 free base) is the isoform of Moxifloxacin Hydrochloride (HY-66011), which is an oral 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia .
    (Rac)-Moxifloxacin-d4
  • HY-B0322A
    Sulfamethoxazole sodium
    10+ Cited Publications

    Ro 4-2130 sodium

    		 Antibiotic Bacterial Infection
    Sulfamethoxazole (Ro 4-2130) sodium is a sulfonamide antibiotic with a widespread antibacterial activity. Sulfamethoxazole sodium inhibits bacterial folate metabolism by competing with 4-Aminobenzoic acid (HY-B1008) (PABA) to act on dihydropteroate synthetase and dihydropteroate reductase. Sulfamethoxazole sodium can be used for the study of urinary tract infections (UTIs), prostatitis, and bronchitis .
    Sulfamethoxazole sodium
  • HY-B0322
    Sulfamethoxazole
    10+ Cited Publications

    Ro 4-2130

    		 Antibiotic Bacterial Infection Cancer
    Sulfamethoxazole (Ro 4-2130) is a sulfonamide antibiotic with a widespread antibacterial activity. Sulfamethoxazole inhibits bacterial folate metabolism by competing with 4-Aminobenzoic acid (HY-B1008) (PABA) to act on dihydropteroate synthetase and dihydropteroate reductase. Sulfamethoxazole can be used for the study of urinary tract infections (UTIs), prostatitis, and bronchitis .
    Sulfamethoxazole
  • HY-19964
    Potassium clavulanate cellulose
    2 Publications Verification

    Potassium clavulanate:cellulose (1:1)

    		 Beta-lactamase Bacterial Antibiotic Infection
    Potassium clavulanate cellulose (Potassium clavulanate:cellulose (1:1)) is a mixture of potassium clavulanate and cellulose, is a bacterial β-lactamase inhibitor. Clavulanate potassium is a form of Clavulanic acid. Clavulanate potassium fights bacteria that resistant to penicillins and other antibiotics. Potassium clavulanate with the combination of amoxicillin can be used for the research of different infections caused by bacteria, such as sinusitis, pneumonia, ear infections, bronchitis, urinary tract infections, and infections of the skin .
    Potassium clavulanate cellulose
  • HY-B0322B
    Sulfamethoxazole 1000 µg/mL in methanol

    Ro 4-2130 1000 µg/mL in methanol

    		 Antibiotic Bacterial Infection
    Sulfamethoxazole (Ro 4-2130) 1000 μg/mL in methanol is a sulfonamide antibiotic with a widespread antibacterial activity. Sulfamethoxazole 1000 μg/mL in methanol inhibits bacterial folate metabolism by competing with 4-Aminobenzoic acid (HY-B1008) (PABA) to act on dihydropteroate synthetase and dihydropteroate reductase. Sulfamethoxazole 1000 μg/mL in methanol can be used for the study of urinary tract infections (UTIs), prostatitis, and bronchitis .
    Sulfamethoxazole 1000 µg/mL in methanol
  • HY-D0184R
    2'-Deoxycytidine (Standard)

    Deoxycytidine (Standard); Cytosine deoxyriboside (Standard); Deoxyribose cytidine (Standard)

    		 Reference Standards Endogenous Metabolite Cancer
    Cefaclor (monohydrate) (Standard) is the analytical standard of Cefaclor (monohydrate). This product is intended for research and analytical applications. Cefaclor is a well-absorbed orally active cephalosporin antibiotic. Cefaclor can specifically bind to specific for penicillin-binding protein 3 (PBP3). Cefaclor can be used for the research of depression and kinds of infections caused by bacteria, such as respiratory tract infections, bacterial bronchitis, pharyngitis and skin infections .
    2'-Deoxycytidine (Standard)
  • HY-B0322R
    Sulfamethoxazole (Standard)

    Ro 4-2130 (Standard)

    		 Reference Standards Antibiotic Bacterial Infection
    Sulfamethoxazole (Standard) (Ro 4-2130 (Standard)) is the analytical standard of Sulfamethoxazole (HY-B0322). This product is intended for research and analytical applications. Sulfamethoxazole (Ro 4-2130) is a sulfonamide antibiotic with a widespread antibacterial activity. Sulfamethoxazole inhibits bacterial folate metabolism by competing with 4-Aminobenzoic acid (HY-B1008) (PABA) to act on dihydropteroate synthetase and dihydropteroate reductase. Sulfamethoxazole can be used for the study of urinary tract infections (UTIs), prostatitis, and bronchitis.
    Sulfamethoxazole (Standard)
  • HY-B0322AR
    Sulfamethoxazole sodium (Standard)

    Ro 4-2130 sodium (Standard)

    		 Reference Standards Antibiotic Bacterial Infection Cancer
    Sulfamethoxazole (Standard) (Ro 4-2130 (Standard)) sodium is the analytical standard of Sulfamethoxazole sodium (HY-B0322A). This product is intended for research and analytical applications. Sulfamethoxazole (Ro 4-2130) sodium is a sulfonamide antibiotic with a widespread antibacterial activity. Sulfamethoxazole sodium inhibits bacterial folate metabolism by competing with 4-Aminobenzoic acid (HY-B1008) (PABA) to act on dihydropteroate synthetase and dihydropteroate reductase. Sulfamethoxazole sodium can be used for the study of urinary tract infections (UTIs), prostatitis, and bronchitis.
    Sulfamethoxazole sodium (Standard)
  • HY-B0322S
    Sulfamethoxazole-d4
    1 Publications Verification

    Ro 4-2130-d4

    		 Isotope-Labeled Compounds Antibiotic Bacterial Infection
    Sulfamethoxazole-d4 (Ro 4-2130-d4) is a deuterium labeled Sulfamethoxazole (HY-B0322). Sulfamethoxazole (Ro 4-2130) is a sulfonamide antibiotic with a widespread antibacterial activity. Sulfamethoxazole inhibits bacterial folate metabolism by competing with 4-Aminobenzoic acid (HY-B1008) (PABA) to act on dihydropteroate synthetase and dihydropteroate reductase. Sulfamethoxazole can be used for the study of urinary tract infections (UTIs), prostatitis, and bronchitis .
    Sulfamethoxazole-d4
  • HY-B0322S1
    Sulfamethoxazole-13C6

    Ro 4-2130-13C6

    		 Isotope-Labeled Compounds Antibiotic Bacterial Infection
    Sulfamethoxazole- 13C6 (Ro 4-2130- 13C6) is a 13C labeled Sulfamethoxazole (HY-B0322). Sulfamethoxazole (Ro 4-2130) is a sulfonamide antibiotic with a widespread antibacterial activity. Sulfamethoxazole inhibits bacterial folate metabolism by competing with 4-Aminobenzoic acid (HY-B1008) (PABA) to act on dihydropteroate synthetase and dihydropteroate reductase. Sulfamethoxazole can be used for the study of urinary tract infections (UTIs), prostatitis, and bronchitis .
    Sulfamethoxazole-13C6

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: